| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 5 Jun 24 | XERS Xeris Biopharma | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 164,144 |
| 15 Mar 24 | XERS Xeris Biopharma | Common Stock | Other | Acquire J | No | No | 0 | 6,474 | 0.00 | 114,144 |
| 7 Feb 24 | LH Laboratory Corporation of America | Common Stock | Option exercise | Acquire M | No | No | 0 | 947 | 0.00 | 11,898 |
| 7 Feb 24 | LH Laboratory Corporation of America | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 947 | 0.00 | 944 |
| 6 Feb 24 | LH Laboratory Corporation of America | RSU Common Stock | Grant | Acquire A | No | No | 0 | 944 | 0.00 | 1,891 |
